[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"primary-osteoarthritis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:primary-osteoarthritis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100564678","dexa-bone-density-analysis-of-the-corehip-prosthesis-system-100564678",false,"NCT06632301","DEXA Bone Density Analysis of the CoreHip® Prosthesis System","DEXA Bone Density Analysis to Analyze the Loading Concept of the CoreHip® Prosthesis","CODEX","Inclusion Criteria:\n\n* Unilateral hip osteoarthritis\n* Indication for CoreHip Standard hip stem according to preoperative planning\n* Written Informed Consent\n* Age 35-85 years\n* According to the assessment of the study doctor, the patient is therapy compliant and able to attend the follow-up visits\n\nExclusion Criteria:\n\n* Femoral neck fractures\n* Pregnancy\n* BMI \\> 35\n* History of femoral fracture or previous surgery on the same hip\n* Metabolic bone disease, use of steroids or other drugs affecting bone metabolism\n* Intraoperative bone cracks\n* Severe osteoarthritis of the contralateral hip\n* THA of the contralateral side or other event leading to restricted weight bearing during the study period","ALL","35 Years","85 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.",[28,29,30,31,32,33],"Primary Osteoarthritis","Cartilage Degeneration","Osteoarthritis, Hip","Inflammatory Arthritis","Osteonecrosis of Femoral Head","Traumatic Disorder",[35,36],"Total Hip Arthroplasty","DEXA Bone Density Analysis","NOT_YET_RECRUITING","2026-02-24",{"date":40,"type":41},"2026-02-27","ACTUAL",{"date":43,"type":22},"2026-06",{"date":45,"type":22},"2028-09",{"name":47,"class":48},"Aesculap AG","INDUSTRY",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":57,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":49},"100510452","clinical-and-radiological-outcomes-of-medacta-shoulder-system-fr-100510452","NCT05926622","Clinical and Radiological Outcomes of Medacta Shoulder System FR","Clinical and Radiological Outcomes of Medacta Shoulder System","Inclusion Criteria:\n\n* Patients older than 18 years\n* Patient with one of the following diagnosis:\n\nPrimary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\\\u003C21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty\n\nExclusion Criteria:\n\n* Patients with malignant diseases (at the time of surgery)\n* Patients with proven or suspect infections (at the time of surgery)\n* Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)\n* Patients with known incompatibility or allergy to products materials (at the time of surgery)","18 Years",{"count":59,"type":22},200,"OBSERVATIONAL","This is a post-marketing surveillance on Medacta Shoulder System",[28,63,64,65,66,67,68],"Secondary Osteoarthritis","Rotator Cuff Tear Arthropathy","Rheumatoid Arthritis Shoulder","Avascular Necrosis","Fracture","Revision of Shoulder Arthroplasty","RECRUITING","2025-09-23",{"date":72,"type":41},"2025-09-29",{"date":74,"type":41},"2022-03-15",{"date":76,"type":22},"2037-03",{"name":78,"class":48},"Medacta International SA"]